SCHEMBL1556596

SCHEMBL1556596

CC(=CCCC(=O)O)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
FNTA P49354 3/20 0.39
FNTB P49356 3/20 0.39
LMNA P02545 2/20 0.39
SLC15A2 Q16348 1/20 0.39
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
FFAR1 O14842 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP19A1 P11511 1/20 0.38
RXRA P19793 1/20 0.38
PPARG P37231 1/20 0.38
OXER1 Q8TDS5 1/20 0.38
ALKBH5 Q6P6C2 1/20 0.35
SUCNR1 Q9BXA5 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
FFAR3 O14843 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1557481 0.87 PPARG (0.41) POLBFNTAFNTBLMNAMAPT
SCHEMBL528543 0.83 LMNA (0.39) POLBLMNAKDM4EATMTRPA1
SCHEMBL528542 0.83 LMNA (0.39) POLBLMNAKDM4EATMTRPA1
SCHEMBL33626 0.81 LMNA (0.42) FNTAFNTBLMNASLC15A2MAPT
SCHEMBL435540 0.81 LMNA (0.42) FNTAFNTBLMNASLC15A2MAPT
SCHEMBL28772870 0.81
SCHEMBL17499861 0.79 PPARG (0.41) FNTAFNTBLMNASLC15A2MAPT
SCHEMBL17499944 0.79 PPARG (0.41) FNTAFNTBLMNASLC15A2MAPT
SCHEMBL11507795 0.78 POLB (0.35) POLBLMNAMAPTALDH1A1MEN1
SCHEMBL11511188 0.78 EP300 (0.37) POLBLMNAMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10166527-B2 Surface modification of porous base supports MERCK PATENT GMBH (DE) 2019-01-01 US claimed
EP-2310104-B1 MIXED GRAFT POLYMERS FOR ION EXCHANGE CHROMATOGRAPHY MERCK PATENT GMBH (DE) 2017-10-18 EP claimed
EP-2152405-B2 GRAFT COPOLYMER FOR CATION-EXCHANGE CHROMATOGRAPHY MERCK PATENT GMBH (DE) 2017-04-05 EP claimed
US-20150298097-A1 SURFACE MODIFICATION OF POROUS BASE SUPPORTS MERCK PATENT GMBH (DE) 2015-10-22 US claimed
EP-2914377-A1 SURFACE MODIFICATION OF POROUS BASE SUPPORTS Merck Patent GmbH (DE) 2015-09-09 EP claimed
WO-2014067605-A1 SURFACE MODIFICATION OF POROUS BASE SUPPORTS MERCK PATENT GMBH (DE) 2014-05-08 WO claimed
US-8673988-B2 Graft copolymers for ion exchange chromatography MERCK PATENT GMBH (DE) 2014-03-18 US claimed
EP-2152405-B1 GRAFT COPOLYMER FOR CATION-EXCHANGE CHROMATOGRAPHY MERCK PATENT GMBH (DE) 2012-10-17 EP claimed
JP-2011529508-A 2011-12-08 JP claimed
US-20110136925-A1 GRAFT COPOLYMERS FOR ION EXCHANGE CHROMATOGRAPHY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-06-09 US claimed
EP-2310104-A1 GRAFT COPOLYMERS FOR ION EXCHANGE CHROMATOGRAPHY Merck Patent GmbH (DE) 2011-04-20 EP claimed
WO-2010012358-A1 GRAFT COPOLYMERS FOR ION EXCHANGE CHROMATOGRAPHY MERCK PATENT GMBH (DE) 2010-02-04 WO claimed
JP-6116287-A None JP disclosed
JP-5097699-A None JP disclosed
US-20250032398-A1 HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2025-01-30 US disclosed
US-11446356-B2 Peptides and related compositions and methods THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2022-09-20 US disclosed
JP-H06116287-A PROPENAMIDE DERIVATIVE, ITS POLYMER AND ITS USE FUJI PHOTO FILM CO LTD 1994-04-26 JP disclosed
JP-H0597699-A CANCER METASTASIS INHIBITOR COMPOSED OF PROPENAMIDE DERIVATIVE POLYMER FUJI PHOTO FILM CO LTD 1993-04-20 JP disclosed
EP-0503301-A2 Peptide derivatives and application thereof FUJI PHOTO FILM CO., LTD. (JP) 1992-09-16 EP disclosed
JP-H00597699-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250032398-A1 HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF PCNA, ADSL, APH1B POLB 216/4885FNTA 2726/4885FNTB 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.